< Back to situations

[ORGANIZATION]

Journal of the American Academy of Dermatology

Featured in 3 tracked stories · first seen

Situations

[QUIET] [HEALTH] [US] [AU] [CA]

Biologic therapy analysis and new HS management guidelines

4 clusters · 5 sources · last updated

Latest: AAD and HSF issue first joint guidelines for hidradenitis suppurativa

Recent medical analyses have evaluated the comparative effectiveness and cost-efficiency of biologic therapies for moderate-to-severe hidradenitis suppurativa (HS), specifically focusing on adalimumab, secukinumab, and b

Also covered in